EPIDAUROS Biotechnologie AG

Area of Science:

• Pharmacogenetics
• Biotechnology
• Drug Development

Background:

• The pharmaceutical and biotechnology industries require specialized services for drug development and therapy.
• Improving the safety, efficacy, and predictability of drugs is a key challenge.
• Pharmacogenetics offers insights into individual drug responses.

Purpose of the Study:

• To provide pharmacogenetic consulting, genotyping, and research services.
• To enhance drug development and drug therapy through personalized medicine approaches.
• To develop innovative diagnostic solutions utilizing intellectual property.

Main Methods:

• In-depth consultancy to determine customer needs in pharmacogenetics.
• Development and execution of genotyping assays for drug-metabolizing enzymes, drug transporters, and drug targets.
• Conducting research services under stringent quality standards.

Main Results:

• Established expertise in pharmacogenetic consulting and assay development.
• Provided services to pharmaceutical companies, contract research organizations, and healthcare providers.
• Facilitated the development of innovative diagnostic solutions.

Conclusions:

• Pharmacogenetic services are crucial for optimizing drug development and therapy.
• EPIDAUROS Biotechnologie AG is a key provider in this specialized field.
• Continued research and development are essential for advancing personalized medicine.